Janus Henderson Group PLC Pyxis Oncology, Inc. Transaction History

Janus Henderson Group PLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.02 - $4.53 $2.82 Million - $6.33 Million	-1,396,967 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$4.04 - $11.43 $291,380 - $824,377	-72,124 Reduced 4.91%	1,396,967 $5.49 Million
Q4 2021 Feb 14, 2022	BUY	$8.39 - $13.64 $12.3 Million - $20 Million	1,469,091 New	1,469,091 $15.3 Million

100

28.2M

539K

54.1K

Ticker PYXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,096,400
Market Cap $55.5M
Description
Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.